Consensus on the curation of chronic cerebral ischemia patients for therapists and general practice physicians


DOI: https://dx.doi.org/10.18565/therapy.2020.7.14-21

EXPERTS:
1. Martynov A.I., MD, professor, academician of the RAS, professor of the Department of hospital therapy No. 1 of A.I. Evdokimov Moscow State University of Medicine and Dentistry of the Ministry of Healthcare of Russia, president of Russian Scientific Medical Society of Internal Medicine 
2. Vertkin A.L., MD, professor, head of the Department of therapy, clinical pharmacology and internal diseases of A.I. Evdokimov Moscow State University of Medicine and Dentistry of the Ministry of Healthcare of Russia, honored scientist of the Russian Federation, head of the Local Education Authority «Outpatient doctor»
3. Danilov An.B., MD, professor, professor of the Department of nervous diseases of I.M. Sechenov First Moscow State Medical University (Sechenov University) of the Ministry of Healthcare of Russia
4. Kozlov I.G., MD, professor, head of the laboratory of experimental and clinical pharmacology of Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology of the Ministry of Healthcare of Russia 
5. Maksimova M.Yu., MD, professor, head of the 2nd neurological Department, chief researcher of Scientific Center of Neurology
6. Mkrtumyan A.M., MD, professor, head of the Department of endocrinology and diabetology of A.I. Evdokimov Moscow State University of Medicine and Dentistry of the Ministry of Healthcare of Russia, honored doctor of the Russian Federation 
7. Putilina M.V., MD, professor of the Department of neurology, faculty of additional professional education of N.I. Pirogov Russian Scientific Research Medical University of the Ministry of Healthcare of Russia 
8. Solovyova E.Yu., MD, professor, head of the laboratory of biomedical research in neurology, professor of the Department of neurology of N.I. Pirogov Russian Scientific Research Medical University of the Ministry of Healthcare of Russia
9. Tabeeva G.R., MD, professor, professor of the Department of nervous diseases and neurosurgery of I.M. Sechenov First Moscow State Medical University (Sechenov University) of the Ministry of Healthcare of Russia, president of the Russian Society for Headache Studies
10. Fedotova A.V., PhD, associate professor of the Department of neurology of N.I. Pirogov Russian Scientific Research Medical University of the Ministry of Healthcare of Russia

Keywords: consensus, outpatient treatment, chronic cerebral ischemia, discirculatory encephalopathy, antioxidants, oxidative stress
Read entire article

Literature


  1. Дамулин И.В., Парфенов В.А., Скоромец А.А., Яхно Н.Н. Нарушения кровообращения в головном и спинном мозге. Болезни нервной системы. Руководство для врачей. Под ред. Н.Н. Яхно. М.: Медицина. 2005; с. 231–302. [Damulin I.V., Parfenov V.A., Skoromets A.A., Yakhno N.N. Circulatory disorders in the brain and spinal cord. Diseases of the nervous system. A guide for physicians. Ed. by Yakhno N.N. M.: Meditsina. 2005; pp. 231–302 (In Russ.)].

  2. Парфенов В.А. Дисциркуляторная энцефалопатия и сосудистые когнитивные расстройства. М.: ИМА-ПРЕСС. 2017; 125 с. [Parfenov V.A. Dyscirculatory encephalopathy and vascular cognitive disorders. M.: IMA-PRESS. 2017; 125 p. (In Russ.)].

  3. Инсульт: современные технологии диагностики и лечения. Под ред. М.А. Пирадова, М.М. Танашян, М.Ю. Максимовой. 3-е изд. М: МЕДпресс-информ. 2018; 360 с. с ил. ISBN 5-98322-566-9. doi: 10.24421/MP.2018.18.15909. [Stroke: modern diagnostic and treatment technologies. Ed. by Piradov M.A., Tanashyan M.M., Maksimova M.Yu. 3rd edition. M.: MEDpress-inform. 2018; 360 p. with ill. ISBN 5-98322-566-9 (In Russ.)]. doi: 10.24421/MP.2018.18.15909.

  4. Путилина М.В. Астенические синдромы при хронической ишемии мозга и их коррекция. Consilium medicum. 2010; 9: 48–51. [Putilina M.V. Asthenic syndromes in chronic cerebral ischemia and their correction. Consilium medicum. 2010; 9: 48–51 (In Russ.)].

  5. Wardlaw J.M., Smith C., Dichgans M. Mechanisms of sporadic cerebral small vessel disease: insights from neuroimaging. Lancet Neurol. 2013; 12(5): 483–97. doi: 10.1016/S1474-4422(13)70060-7.

  6. Суслина З.А., Гулевская Т.С., Максимова М.Ю., Моргунов В.А. Нарушения мозгового кровообращения: диагностика, лечение, профилактика. М.: МЕДпресс-информ. 2016; 536 с. [Suslina Z.A., Gulevskaya T.S., Maksimova M.Yu., Morgunov V.A. Diagnosis, treatment and prevention of cerebral circulation disorders. M.: MEDpress-inform. 2016; 536 p. (In Russ.)].

  7. Инструкция по медицинскому применению препарата Мексиприм®: таблетки (Р N001916/02), раствор для внутривенного и внутримышечного введения (ЛС-001668). grls.rosminzdrav.ru (дата обращения – 01.10.2020).

  8. Танашян М.М., Лагода О.В., Федин П.А. с соавт. Антиоксидантная терапия хронических цереброваскулярных заболеваний. РМЖ. 2010; 8: 487–490. [Tanashyan M.M., Lagoda O.V., Fedin P.A. et al. Antioxidant therapy of chronic cerebrovascular diseases. Rossiysky meditsinsky zhurnal. 2010; 8: 487–490 (In Russ.)].

  9. Кукес В., Шилер Л., Хаджиева Б., Беляева С. Применение препарата Мексиприм в терапии цереброваскулярной болезни. Врач. 2008; 3: 31–34. [Kukes V., Shiler L., Khajieva B., Belyaeva S. Application of the drug Mexiprim in the treatment of cerebrovascular disease. Vrach. 2008; 3: 31–34 (In Russ.)].

  10. Путилина М.В. Современные представления о терапии тревожно–депрессивных расстройств при хронической ишемии головного мозга. РМЖ. 2011; 2: 1–6. [Putilina M.V. Modern ideas about the therapy of anxiety – depressive disorders in chronic cerebral ischemia. Rossiysky meditsinsky zhurnal. 2011; 2: 1–6 (In Russ.)].

  11. Курушина О.В., Барулин А.Е., Коновалова О.В. Коррекция психоэмоциональных и вегетативных нарушений у пациентов, перенесших ишемический инсульт. Журнал неврологии и психиатрии им. C.C. Корсакова. 2013; 9–2: 50–54. [Kurushina O.V., Barulin A.E., Konovalova O.V. Correction of psychoemotional and autonomic dysfunction in patients with ischemic stroke. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova. 2013; 9–2: 50–54 (In Russ.)].

  12. Куцемелов И.Б., Кушнарева В.В., Ефремов В.В., Ерофеева А.В. Применение современных антиоксидантов (Мексиприм) в комплексном лечении больных с хронической цереброваскулярной недостаточностью. РМЖ. 2012; 10: 509–513. [Kutsemelov I.B., Kusnareva V.V., Efremov V.V., Erofeeva A.V. The use of modern antioxidants (Mexiprim) in the complex treatment of patients with chronic cerebrovascular insufficiency. Russky meditsinsky zhurnal. 2012; 10: 509–513 (In Russ.)].

  13. Костенко Е.В., Петрова Л.В., Зайцев К.А. с соавт. Опыт применения антиоксидантной терапии (Мексиприм) при лечении больных в раннем восстановительном периоде ишемического инсульта полушарной локализации. РМЖ. 2010; 26: 1619–1623. [Kostenko E.V., Petrova L.V., Zaytsev K.A. et al. Experience in the use of antioxidant therapy (Mexiprim) in the treatment of patients in the early recovery period of ischemic stroke of hemispheric localization. Russky meditsinsky zhurnal. 2010; 26: 1619–1623(In Russ.)].

  14. Путилина М.В., Теплова Н.В. Рациональная фармакотерапия хронической ишемии головного мозга. М.: МЕДпресс-информ. 2019; 472 c. [Putilina M.V., Teplova N.V. Rational pharmacotherapy of chronic cerebral ischemia. M.: MEDpress-inform. 2019; 472 p. (In Russ.)].

Back to Content

Бионика Медиа